티씨노바이오사이언스
1 known investors
TXINNO is a biotech company developing small-molecule innovative anticancer drugs, with a scientific focus on the innate immune system and RAS signaling pathways. Its work spans drug discovery platforms and a therapeutic pipeline aimed at treating cancer patients.
Investors · 1
Frequently asked questions
- What does 티씨노바이오사이언스 do?
- TXINNO is a biotech company developing small-molecule innovative anticancer drugs, with a scientific focus on the innate immune system and RAS signaling pathways. Its work spans drug discovery platforms and a therapeutic pipeline aimed at treating cancer patients.
- Who are 티씨노바이오사이언스's investors?
- 티씨노바이오사이언스's investors include Solidus Investment.